Stock Scorecard
Stock Summary for Doximity Inc - Class A (DOCS) - $29.49 as of 10/9/2026 6:46:59 PM EST
Total Score
12 out of 30
Safety Score
49 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DOCS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DOCS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DOCS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DOCS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DOCS (49 out of 100)
| Stock Price Rating (Max of 10) | 7 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 3 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 5 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DOCS
Financial Details for DOCS
Company Overview |
|
|---|---|
| Ticker | DOCS |
| Company Name | Doximity Inc - Class A |
| Country | USA |
| Description | Doximity, Inc. (Ticker: DOCS) is a U.S. healthcare technology company that operates a digital platform tailored for medical professionals. The company’s cloud-based network provides secure communication and collaboration tools, telemedicine services, clinical workflow solutions, and access to medical news, research, and career-management features for physicians, nurse practitioners, physician assistants, and other clinicians. Headquartered in San Francisco, California, Doximity’s Class A common stock trades on the New York Stock Exchange under the ticker DOCS. |
| Sector Name | HEALTHCARE |
| Industry Name | HEALTH INFORMATION SERVICES |
| Most Recent Quarter | 6/30/2026 |
| Next Earnings Date | 11/5/2026 |
Stock Price History |
|
| Last Day Price | 29.49 |
| Price 4 Years Ago | 33.56 |
| Last Day Price Updated | 10/9/2026 6:46:59 PM EST |
| Last Day Volume | 5,196,834 |
| Average Daily Volume | 2,903,502 |
| 52-Week High | 72.24 |
| 52-Week Low | 17.15 |
| Last Price to 52 Week Low | 71.95% |
Valuation Measures |
|
| Trailing PE | 32.58 |
| Industry PE | 47.87 |
| Sector PE | 38.56 |
| 5-Year Average PE | 56.37 |
| Free Cash Flow Ratio | 13.72 |
| Industry Free Cash Flow Ratio | 24.15 |
| Sector Free Cash Flow Ratio | 32.29 |
| Current Ratio Most Recent Quarter | 6.08 |
| Total Cash Per Share | 2.15 |
| Book Value Per Share Most Recent Quarter | 5.09 |
| Price to Book Ratio | 5.17 |
| Industry Price to Book Ratio | 9.41 |
| Sector Price to Book Ratio | 8.69 |
| Price to Sales Ratio Twelve Trailing Months | 7.53 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.96 |
| Sector Price to Sales Ratio Twelve Trailing Months | 8.43 |
| Analyst Buy Ratings | 3 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 127,349,000 |
| Market Capitalization | 3,755,522,010 |
| Institutional Ownership | 102.32% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -51.90% |
| Annual Earnings Growth | -12.16% |
| Reported EPS 12 Trailing Months | 0.85 |
| Reported EPS Past Year | 0.14 |
| Reported EPS Prior Year | 1.44 |
| Net Income Twelve Trailing Months | 167,046,000 |
| Net Income Past Year | 196,051,000 |
| Net Income Prior Year | 223,185,000 |
| Quarterly Revenue Growth YOY | 7.30% |
| 5-Year Revenue Growth | 25.53% |
| Operating Margin Twelve Trailing Months | 21.50% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 273,604,000 |
| Total Cash Past Year | 219,178,000 |
| Total Cash Prior Year | 209,614,000 |
| Net Cash Position Most Recent Quarter | 273,604,000 |
| Net Cash Position Past Year | 219,178,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 950,837,000 |
| Total Stockholder Equity Prior Year | 1,082,625,000 |
| Total Stockholder Equity Most Recent Quarter | 916,070,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 299,285,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.35 |
| Free Cash Flow Past Year | 317,495,000 |
| Free Cash Flow Prior Year | 266,740,000 |
Options |
|
| Put/Call Ratio | 0.66 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.59 |
| MACD Signal | 0.47 |
| 20-Day Bollinger Lower Band | 17.65 |
| 20-Day Bollinger Middle Band | 23.35 |
| 20-Day Bollinger Upper Band | 29.04 |
| Beta | 1.22 |
| RSI | 65.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 10/8/2026 10:51:17 PM EST |